Pharmacokinetics of mycophenolate mofetil in heart transplant recipients

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 801-803

  Seebacher, G ^a   Mallinger, R ^a   Laufer, G ^a   Grimm, M ^a   Griesmacher, A ^b   Weigel, G ^a   Wolner, E ^a   Muller M M ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031862458     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_154     Document Type: Conference Paper

References (5)

1. J. T. Ransom, Mechanism of Action of Mycophenolate Mofetil. Therapeutic Drug Monitoring 17:681-684 (1995).
2. A. C. Allison, W. J. Kowalski, C. J. Muller, R. V. Waters, and E. M. Eugui, Mycophenolic Acid and Brequinar, Inhibitors of Purine and Pyrimidine Synthesis, Block the Glycosylation of Adhesion Molecules. Transplant Proceedings 25, Suppl. 2: 67-70 (1993).
3. L. M. Shaw, H. W. Sollinger, P. Halloran, R. E. Morris, R. W. Yatscoff, J. Ransom, I. Tsina, P. Keown, D. W. Holt, R. Lieberman, A. Jaklitsch, and J. Potter, Mycophenolate Mofetil: A Report of the Consensus Panel. Therapeutic Drug Monitoring 17:690-699 (1995).
4. European Mycophenolate Mofetil Cooperative Study Group, Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325(1995).
5. H. W. Sollinger for the U. S. Renal Transplant Mycophenolate Mofetil Study Group, Mycophenolate Mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60:225-232(1995).